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APPENDIX A: INFECTION PREVENTION CHECKLIST  
FOR OUTPATIENT SETTINGS 
This checklist is a companion to the Guide to Infection Prevention for Outpatient Settings: Minimum 
Expectations for Safe Care and is intended to assist in the assessment of infection control programs and 
practices in outpatient settings.  The checklist should be used:
1. To ensure that the facility has appropriate infection prevention policies and procedures in place and 
supplies to allow healthcare personnel (HCP) to provide safe care.
2. To systematically assess personnel adherence to correct infection prevention practices. In order to 
complete the assessment, direct observation of infection control practices will be necessary. 
Providers using this checklist should identify all procedures performed in their facility and refer to 
appropriate sections to conduct their evaluation.  Certain sections may not apply (e.g., some settings may 
not perform sterilization or high-level disinfection).  If the answer to any of the listed questions is No, 
efforts should be made to correct the practice, appropriately educate HCP (if applicable), and determine 
why the correct practice was not being performed.  Consideration should also be made for determining 
the risk posed to patients by the deficient practice.  Certain infection control lapses (e.g., re-use of syringes 
on more than one patient or to access a medication container that is used for subsequent patients; re-
use of lancets) have resulted in bloodborne pathogen transmission and should be halted immediately. 
Identification of such lapses warrants immediate consultation with the state or local health department and 
appropriate notification and testing of potentially affected patients.
Overview
Section 1: Facility Demographics
Section 2: Infection Control Program and Infrastructure
Section 3: Direct Observation of Facility Practices
Section 4: Infection Control Guidelines and Other Resources
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Infection Control Domains for Gap Assessment
I.  Infection Control Program and Infrastructure
II.  Infection Control Training and Competency
III.  Healthcare Personnel Safety
IV.  Surveillance and Disease Reporting
V.a/b.  Hand Hygiene
VI.a/b.  Personal Protective Equipment (PPE)
VII.a/b.  Injection Safety
VIII.a/b.  Respiratory Hygiene/Cough Etiquette
IX.a/b.  Point-of-Care Testing (if applicable)
X.a/b.  Environmental Cleaning
XI.a/b.   Device Reprocessing (if applicable)
XII.  Sterilization of Reusable Devices (if applicable)
XIII.  High-level Disinfection of Reusable Devices (if applicable)
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Section 1: Facility Demographics
Questions Details
Is the facility licensed 
by the state?
  Yes              No  
If yes,
Date of last inspection:  ___________________
Were any infection control deficiencies identified during last inspection?     
  Yes              No   
If Yes, ensure those elements are evaluated during the assessment. 
Is the facility certified 
by the Centers for 
Medicare & Medicaid 
Services (CMS)? 
  Yes              No   
If yes,
Date of last inspection:  ___________________
Were any infection control deficiencies identified during last inspection?     
  Yes              No   
If Yes, ensure those elements are evaluated during the assessment.
Is the facility 
accredited?
  Yes              No       
If yes, 
List the accreditation organization:
       Accreditation Association for Ambulatory Health Care (AAAHC)
       American Association for Accreditation of Ambulatory Surgery 
          Facilities (AAAASF)
       American Osteopathic Association (AOA)
       The Joint Commission (TJC)
       Other (specify):  _______________________
Date of last inspection:  ______________________
Were any infection control deficiencies identified during last inspection?     
  Yes              No   
If Yes, ensure those elements are evaluated during the assessment.
Is the facility affiliated 
with a hospital?
  Yes    
 No      
If yes, consider engaging with the hospital infection prevention program for assistance 
in remediation of any identified lapses.
Which procedures 
are performed by the 
facility?
Select all that apply.
Chemotherapy, Endoscopy, Ear/Nose/Throat
Imaging (MRI/CT), Immunizations, OB/Gyn
Ophthalmologic, Orthopedic, Pain remediation
Plastic/reconstructive, Podiatry, Other (specify)
  
  Chemotherapy
  Imaging (MRI/CT)
  Ophthalmologic
  Plastic/reconstructive
  Endoscopy
  Immunizations
  Orthopedic
  Podiatry
  Ear/Nose/Throat
  OB/Gyn
  Pain remediation
  Other (specify)
4
Version 2.2 - November 2015
Section 2: Infection Control Program and Infrastructure
I. Infection Control Program and Infrastructure
Elements to be assessed Assessment Notes/Areas for Improvement
A.   Written infection prevention policies and procedures are 
available, current, and based on evidence-based guidelines 
(e.g., CDC/HICPAC), regulations, or standards.
Note: Policies and procedures should be appropriate for the 
services provided by the facility and should extend beyond 
OSHA bloodborne pathogen training
 Yes     No
B.   Infection prevention policies and procedures are re-
assessed at least annually or according to state or federal 
requirements, and updated if appropriate.
 Yes     No
C.   At least one individual trained in infection prevention is 
employed by or regularly available (e.g., by contract) to 
manage the facility’s infection control program.
Note:  Examples of training may include:  Successful completion 
of initial and/or recertification exams developed by the 
Certification Board for Infection Control & Epidemiology; 
participation in infection control courses organized by the state 
or recognized professional societies (e.g., APIC, SHEA).
 Yes     No
D.   Facility has system for early detection and management of 
potentially infectious persons at initial points of patient 
encounter.
Note:  System may include taking a travel and occupational 
history, as appropriate, and elements described under respiratory 
hygiene/cough etiquette.
 Yes     No
II. Infection Control Training and Competency 
Elements to be assessed Assessment
Notes/Areas for 
Improvement
A.   Facility has a competency-based training program that 
provides job-specific training on infection prevention policies 
and procedures to healthcare personnel.
Note: This includes those employed by outside agencies and 
available by contract or on a volunteer basis to the facility.
See sections below for more specific assessment of training 
related to: hand hygiene, personal protective equipment (PPE), 
injection safety, environmental cleaning, point-of-care testing, 
and device reprocessing.
 Yes     No
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III. Healthcare Personnel Safety
Elements to be assessed Assessment
Notes/Areas for 
Improvement
A.   Facility has an exposure control plan that is tailored to the 
specific requirements of the facility (e.g., addresses potential 
hazards posed by specific services provided by the facility).
Note: A model template, which includes a guide for creating an 
exposure control plan that meets the requirements of the OSHA 
Bloodborne Pathogens Standard is available at: https://www.
osha.gov/Publications/osha3186.pdf 
 Yes     No
B.   HCP for whom contact with blood or other potentially 
infectious material is anticipated are trained on the OSHA 
bloodborne pathogen standard upon hire and at least 
annually.
 Yes     No
C.   Following an exposure event, post-exposure evaluation and 
follow-up, including prophylaxis as appropriate, are available 
at no cost to employee and are supervised by a licensed 
healthcare professional.
Note:  An exposure incident refers to a specific eye, mouth, other 
mucous membrane, non-intact skin, or parenteral contact with 
blood or other potentially infectious materials that results from 
the performance of an individual’s duties.
 Yes     No 
D.   Facility tracks HCP exposure events and evaluates event data 
and develops/implements corrective action plans to reduce 
incidence of such events.
 Yes     No
E.   Facility follows recommendations of the Advisory 
Committee on Immunization Practices (ACIP) for 
immunization of HCP, including offering Hepatitis B and 
influenza vaccination.
Note: Immunization of Health-Care Personnel: 
Recommendations of the ACIP available at: http://www.cdc.
gov/mmwr/preview/mmwrhtml/rr6007a1.htm
 Yes     No
F.   All HCP receive baseline tuberculosis (TB) screening prior to 
placement, and those with potential for ongoing exposure to 
TB receive periodic screening (if negative) at least annually.  
 Yes     No
G.   If respirators are used, the facility has a respiratory 
protection program that details required worksite-specific 
procedures and elements for required respirator use, 
including provision of medical clearance, training, and fit 
testing as appropriate.
 Yes     No
 Not Applicable
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III. Healthcare Personnel Safety (continued) 
Elements to be assessed Assessment
Notes/Areas for 
Improvement
H.  Facility has well-defined policies concerning contact of 
personnel with patients when personnel have potentially 
transmissible conditions. These policies include:
i. Work-exclusion policies that encourage reporting of 
illnesses and do not penalize with loss of wages, benefits, 
or job status.
ii. Education of personnel on prompt reporting of illness to  
supervisor.
 Yes     No 
 Yes     No 
 Yes     No
IV. Surveillance and Disease Reporting
Elements to be assessed Assessment
Notes/Areas for 
Improvement
A.   An updated list of diseases reportable to the public health 
authority is readily available to all personnel.
 Yes     No
B.   Facility can demonstrate knowledge of and compliance with 
mandatory reporting requirements for notifiable diseases, 
healthcare associated infections (as appropriate), and for 
potential outbreaks.
 Yes     No
C.   Patients who have undergone procedures at the facility are 
educated regarding signs and symptoms of infection that 
may be associated with the procedure and instructed to 
notify the facility if such signs or symptoms occur.
 Yes     No
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V.a. Hand Hygiene
Elements to be assessed Assessment
Notes/Areas for 
Improvement
A.   All HCP are educated regarding appropriate indications for 
hand hygiene:
i. Upon hire, prior to provision of care
ii. Annually
 Yes     No
 Yes     No
B.   HCP are required to demonstrate competency with hand 
hygiene following each training.
 Yes     No
C.   Facility regularly audits (monitors and documents) 
adherence to hand hygiene. 
 Yes     No
D.   Facility provides feedback from audits to personnel 
regarding their hand hygiene performance.
 Yes     No
E.   Hand hygiene policies promote preferential use of alcohol-
based hand rub over soap and water in all clinical situations 
except when hands are visibly soiled (e.g., blood, body fluids) 
or after caring for a patient with known or suspected  
C. difficile or norovirus.
 Yes     No
VIa. Personal Protective Equipment (PPE)
Elements to be assessed Assessment
Notes/Areas for 
Improvement
A.   HCP who use PPE receive training on proper selection and 
use of PPE:
i. Upon hire, prior to provision of care
ii. Annually
iii. When new equipment or protocols are introduced
 Yes     No
 Yes     No
 Yes     No
B.   HCP are required to demonstrate competency with selection 
and use of PPE following each training.  
 Yes     No
C.   Facility regularly audits (monitors and documents) 
adherence to proper PPE selection and use. 
 Yes     No
D.   Facility provides feedback from audits to personnel 
regarding their performance with selection and use of PPE.
 Yes     No
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VII.a.  Injection Safety (This element does not include assessment of pharmacy/ 
compounding practices)
Elements to be assessed Assessment
Notes/Areas for 
Improvement
A.   HCP who prepare and/or administer parenteral medications 
receive training on safe injection practices:
i. Upon hire, prior to being allowed to prepare and/or 
administer parenteral medications
ii. Annually
iii. When new equipment or protocols are introduced 
 Yes     No
 Yes     No
 Yes     No
B.   HCP are required to demonstrate competency with safe 
injection practices following each training.
 Yes     No
C.   Facility regularly audits (monitors and documents) 
adherence to safe injection practices.
 Yes     No
D.   Facility provides feedback from audits to personnel 
regarding their adherence to safe injection practices.
 Yes     No
E.   Facility has policies and procedures to track HCP access to 
controlled substances to prevent narcotics theft/diversion.
Note: Policies and procedures should address: how data are 
reviewed, how facility would respond to unusual access patterns, 
how facility would assess risk to patients if tampering (alteration 
or substitution) is suspected or identified, and who the facility 
would contact if diversion is suspected or identified.
 Yes     No
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VIII.a. Respiratory Hygiene/Cough Etiquette
Elements to be assessed Assessment
Notes/Areas for 
Improvement
A.   Facility has policies and procedures to contain respiratory 
secretions in persons who have signs and symptoms of a 
respiratory infection, beginning at point of entry to the 
facility and continuing through the duration of the visit.  
Policies include: 
i. Offering facemasks to coughing patients and other 
symptomatic persons upon entry to the facility, at a 
minimum, during periods of increased respiratory 
infection activity in the community.
ii. Providing space in waiting rooms and encouraging 
persons with symptoms of respiratory infections to sit as 
far away from others as possible.  
Note: If available, facilities may wish to place patients with 
symptoms of a respiratory infection in a separate area while 
waiting for care.
 Yes     No 
 Yes     No 
 Yes     No 
B.   Facility educates HCP on the importance of infection 
prevention measures to contain respiratory secretions to 
prevent the spread of respiratory pathogens.
 Yes     No
IX.a. Point-of-Care Testing (e.g., blood glucose meters, INR monitor)
Elements to be assessed Assessment
Notes/Areas for 
Improvement
A.   HCP who perform point-of-care testing receive training on 
recommended practices:
i. Upon hire, prior to being allowed to perform point-of-
care testing
ii. Annually
iii. When new equipment or protocols are introduced 
 Yes     No
 Yes     No
 Yes     No
 Not applicable  
B.   HCP are required to demonstrate competency with 
recommended practices for point-of-care testing following 
each training.
 Yes     No
 Not applicable  
C.   Facility regularly audits (monitors and documents) 
adherence to recommended practices during point-of-care 
testing.
 Yes     No
 Not applicable  
D.   Facility provides feedback from audits to personnel 
regarding their adherence to recommended practices.
 Yes     No
 Not applicable  
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X.a.  Environmental Cleaning
Elements to be assessed Assessment Notes/Areas for Improvement
A.   Facility has written policies and procedures for routine 
cleaning and disinfection of environmental surfaces, 
including identification of responsible personnel.
 Yes     No
B.   Personnel who clean and disinfect patient care areas (e.g., 
environmental services, technicians, nurses) receive training 
on cleaning procedures:
i. Upon hire, prior to being allowed to perform 
environmental cleaning
ii. Annually
iii. When new equipment or protocols are introduced
Note:  If environmental cleaning is performed by contract 
personnel, facility should verify this is provided by contracting 
company.
 Yes     No
 Yes     No
 Yes     No
C.   HCP are required to demonstrate competency with 
environmental cleaning procedures following each training.
 Yes     No
D.   Facility regularly audits (monitors and documents) 
adherence to cleaning and disinfection procedures, 
including using products in accordance with manufacturer’s 
instructions (e.g., dilution, storage, shelf-life, contact time). 
 Yes    No
E.   Facility provides feedback from audits to personnel regarding 
their adherence to cleaning and disinfection procedures.
 Yes     No
F.   Facility has a policy/procedure for decontamination of spills 
of blood or other body fluids.
 Yes     No
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X.a.  Environmental Cleaning (continued) – Operating room
Elements to be assessed Assessment
Notes/Areas for 
Improvement
G.   Operating rooms are terminally cleaned after last procedure 
of the day.
 Yes     No
 Not applicable  
H.   Facility regularly audits (monitors and documents) 
adherence to recommended infection control practices for 
surgical infection prevention including:
i. Adherence to preoperative surgical scrub and hand 
hygiene
ii. Appropriate use of surgical attire and drapes
iii. Adherence to aseptic technique and sterile field
iv. Proper ventilation requirements in surgical suites
v. Minimization of traffic in the operating room
vi. Adherence to cleaning and disinfection of environmental 
surfaces 
 Yes     No
 Yes     No
 Yes     No
 Yes     No
 Yes     No
 Yes     No
 Not applicable  
I.   Facility provides feedback from audits to personnel regarding 
their adherence to surgical infection prevention practices. 
 Yes     No
 Not applicable  
XI.a.  Device Reprocessing
The following basic information allows for a general assessment of policies and procedures related to 
reprocessing of reusable medical devices.  Outpatient facilities that are performing on-site sterilization or 
high-level disinfection of reusable medical devices should refer to the more detailed checklists in separate 
sections of this document devoted to those issues.  
Categories of Medical Devices:
• Critical items (e.g., surgical instruments) are objects that enter sterile tissue or the vascular system and 
must be sterile prior to use (see Sterilization Section).  
• Semi-critical items (e.g., endoscopes for upper endoscopy and colonoscopy, vaginal probes) are objects 
that contact mucous membranes or non-intact skin and require, at a minimum, high-level disinfection 
prior to reuse (see High-level Disinfection Section).  
• Non-critical items (e.g., blood pressure cuffs) are objects that may come in contact with intact skin 
but not mucous membranes and should undergo cleaning and low- or intermediate-level disinfection 
depending on the nature and degree of contamination.
Single-use devices (SUDs) are labeled by the manufacturer for a single use and do not have reprocessing 
instructions.  They may not be reprocessed for reuse except by entities which have complied with FDA 
regulatory requirements and have received FDA clearance to reprocess specific SUDs.  
Note: Cleaning must always be performed prior to sterilization and disinfection
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XI.a.  Device Reprocessing (continued)
Elements to be assessed Assessment
Notes/Areas for 
Improvement
A.   Facility has policies and procedures to ensure that reusable 
medical devices are cleaned and reprocessed appropriately 
prior to use on another patient.
Note: This includes clear delineation of responsibility among 
HCP for cleaning and disinfection of equipment including, 
non-critical equipment, mobile devices, and other electronics 
(e.g., point-of-care devices) that might not be reprocessed in a 
centralized reprocessing area.
 Yes     No
B.   The individual(s) in charge of infection prevention at the 
facility is consulted whenever new devices or products will 
be purchased or introduced to ensure implementation of 
appropriate reprocessing policies and procedures.
 Yes    No
C.   HCP responsible for reprocessing reusable medical devices 
receive hands-on training on proper selection and use of PPE 
and recommended steps for reprocessing assigned devices:
i. Upon hire, prior to being allowed to reprocess devices
ii. Annually
iii. When new devices are introduced or policies/procedures 
change.
Note:  If device reprocessing is performed by contract personnel, 
facility should verify this is provided by contracting company.
 Yes     No 
 Yes     No 
 Yes     No
D.   HCP are required to demonstrate competency with 
reprocessing procedures (i.e., correct technique is observed 
by trainer) following each training.
 Yes     No
E.   Facility regularly audits (monitors and documents) adherence 
to reprocessing procedures.
 Yes     No
F.   Facility provides feedback from audits to personnel regarding 
their adherence to reprocessing procedures.
 Yes     No
G.   Facility has protocols to ensure that HCP can readily 
identify devices that have been properly reprocessed and 
are ready for patient use (e.g., tagging system, storage in 
designated area).
 Yes     No
H.  Facility has policies and procedures outlining facility 
response (i.e., risk assessment and recall of device) in the 
event of a reprocessing error or failure.
 Yes     No
I.   Routine maintenance for reprocessing equipment (e.g., 
automated endoscope reprocessors, steam autoclave) is 
performed by qualified personnel in accordance with 
manufacturer instructions; confirm maintenance records are 
available.
 Yes     No
 Not applicable 
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Section 3:  Direct Observation of Facility Practices
V.b. Hand hygiene
Elements to be assessed Assessment
Notes/Areas for 
Improvement
A.   Supplies necessary for adherence to hand hygiene (e.g., soap, 
water, paper towels, alcohol-based hand rub) are readily 
accessible to HCP in patient care areas.
 Yes     No
Hand hygiene is performed correctly: blank blank
B.   Before contact with the patient 
C.   Before performing an aseptic task (e.g., insertion of IV or 
preparing an injection) 
D.  After contact with the patient
E.   After contact with objects in the immediate vicinity of  
the patient
F.   After contact with blood, body fluids or contaminated 
surfaces 
G.  After removing gloves
H.   When moving from a contaminated-body site to a clean-
body site during patient care
 Yes     No 
 Yes     No 
 Yes     No 
 Yes     No 
 Yes     No 
 Yes     No 
 Yes     No
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VI.b. Personal Protective Equipment (PPE)
Elements to be assessed Assessment Notes/Areas for Improvement
A.   Sufficient and appropriate PPE is available and readily 
accessible to HCP.
 Yes     No
PPE is used correctly:
B.   PPE, other than respirator, is removed and discarded prior to 
leaving the patient’s room or care area.  If a respirator is used, 
it is removed and discarded (or reprocessed if reusable) after 
leaving the patient room or care area and closing the door.  
 Yes     No
C.   Hand hygiene is performed immediately after  
removal of PPE.
 Yes     No
D.  Gloves
i. HCP wear gloves for potential contact with blood, 
body fluids, mucous membranes, non-intact skin, or 
contaminated equipment.
ii. HCP do not wear the same pair of gloves for the care of 
more than one patient.
iii. HCP do not wash gloves for the purpose of reuse.
 Yes     No
 Yes     No 
 Yes     No
E.  Gowns
i. HCP wear gowns to protect skin and clothing during 
procedures or activities where contact with blood or 
body fluids is anticipated.
ii. HCP do not wear the same gown for the care of more 
than one patient.
 Yes     No 
 Not applicable    
 Yes     No 
 Not applicable    
F.  Facial protection
i. HCP wear mouth, nose, and eye protection during 
procedures that are likely to generate splashes or sprays 
of blood or other body fluids.
 Yes     No 
 Not applicable    
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VII.b. Injection safety (This element does not include assessment of pharmacy/ 
compounding practices)
Elements to be assessed Assessment
Notes/Areas for 
Improvement
A.   Injections are prepared using aseptic technique in a clean 
area free from contamination or contact with blood, body 
fluids or contaminated equipment.
 Yes     No
B.   Needles and syringes are used for only one patient (this 
includes manufactured prefilled syringes and cartridge 
devices such as insulin pens).
 Yes     No
C.   The rubber septum on a medication vial is disinfected with 
alcohol prior to piercing.
 Yes     No
D.   Medication containers are entered with a new needle and a 
new syringe, even when obtaining additional doses for the 
same patient.
 Yes     No
E.   Single dose (single-use) medication vials, ampules, and bags 
or bottles of intravenous solution are used for only one 
patient.
 Yes     No
F.   Medication administration tubing and connectors are used 
for only one patient.
 Yes     No
G.   Multi-dose vials are dated by HCP when they are 
first opened and discarded within 28 days unless the 
manufacturer specifies a different (shorter or longer) date for 
that opened vial.
Note: This is different from the expiration date printed on the 
vial.
 Yes     No
 Not applicable 
(Facility does not 
use multi-dose 
vials or discards 
them after single 
patient use)    
H.   Multi-dose vials to be used for more than one patient are 
kept in a centralized medication area and do not enter the 
immediate patient treatment area (e.g,. operating room, 
patient  room/cubicle). 
Note: If multi-dose vials enter the immediate patient treatment 
area they should be dedicated for single-patient use and 
discarded immediately after use.
 Yes     No
 Not applicable 
(Facility does not 
use multi-dose 
vials or discards 
them after single 
patient use)    
I.   All sharps are disposed of in a puncture-resistant sharps 
container.
 Yes     No
J.   Filled sharps containers are disposed of in accordance with 
state regulated medical waste rules.
 Yes     No
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Elements to be assessed Assessment
Notes/Areas for 
Improvement
K.   All controlled substances (e.g., Schedule II, III, IV, V drugs) 
are kept locked within a secure area.
 Yes     No
L.   HCP wear a facemask (e.g., surgical mask) when placing a 
catheter or injecting material into the epidural or subdural 
space (e.g., during myelogram, epidural or spinal anesthesia).
 Yes     No
 Not applicable 
(Facility does 
not perform 
spinal injection 
procedures)  
VIII.b. Respiratory Hygiene/Cough Etiquette
Elements to be assessed Assessment Notes/Areas for Improvement
A.  Facility:
i. Posts signs at entrances with instructions to patients with 
symptoms of respiratory infection to:
a. Inform HCP of symptoms of a respiratory infection 
when they first register for care, and
b. Practice Respiratory Hygiene/Cough Etiquette 
(cover their mouths/noses when coughing or 
sneezing, use and dispose of tissues, and perform 
hand hygiene after hands have been covered with 
respiratory secretions).
ii. Provides tissues and no-touch receptacles for disposal of 
tissues.
iii. Provides resources for performing hand hygiene in or 
near waiting areas.
 Yes     No
 Yes     No
 Yes     No
VII.b. Injection safety (This element does not include assessment of pharmacy/ 
compounding practices) (continued)
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IX.b. Point-of-Care Testing (e.g., blood glucose meters, INR monitor)
Elements to be assessed Assessment Notes/Areas for Improvement
A.   New single-use, auto-disabling lancing device is used for 
each patient. 
Note: Lancet holder devices are not suitable for multi-patient 
use.
 Yes     No
 Not applicable 
B.   If used for more than one patient, the point-of-care testing 
meter is cleaned and disinfected after every use according to 
manufacturer’s instructions.  
Note: If the manufacturer does not provide instructions for 
cleaning and disinfection, then the testing meter should not be 
used for >1 patient.
 Yes     No
 Not applicable 
X.b. Environmental Cleaning
Elements to be assessed Assessment Notes/Areas for Improvement
A.   Supplies necessary for appropriate cleaning and disinfection 
procedures (e.g., EPA-registered disinfectants) are available. 
Note: If environmental services are performed by contract 
personnel, facility should verify that appropriate EPA-registered 
products are provided by contracting company
 Yes     No
B.   High-touch surfaces in rooms where surgical or other 
invasive procedures (e.g., endoscopy, spinal injections) are 
performed are cleaned and then disinfected with an EPA-
registered disinfectant after each procedure.
 Yes     No
 Not applicable  
C.   Cleaners and disinfectants are used in accordance with 
manufacturer’s instructions (e.g., dilution, storage, shelf-life, 
contact time).
 Yes     No
D.   HCP engaged in environmental cleaning wear appropriate 
PPE to prevent exposure to infectious agents or chemicals 
(PPE can include gloves, gowns, masks, and eye protection).
Note: The exact type of correct PPE depends on infectious or 
chemical agent and anticipated type of exposure.
 Yes     No
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XI.b. Device Reprocessing
Elements to be assessed Assessment
Notes/Areas for 
Improvement
A.   Policies, procedures, and manufacturer reprocessing 
instructions for reusable medical devices used in the facility 
are available in the reprocessing area(s).
 Yes     No
B.   Reusable medical devices are cleaned, reprocessed 
(disinfection or sterilization) and maintained according to 
the manufacturer instructions.
Note: If the manufacturer does not provide such instructions, the 
device may not be suitable for multi-patient use.
 Yes     No
C.   Single-use devices are discarded after use and not used for 
more than one patient.
Note: If the facility elects to reuse single-use devices, these devices 
must be reprocessed prior to reuse by a third-party reprocessor 
that it is registered with the FDA as a third-party reprocessor 
and cleared by the FDA to reprocess the specific device in 
question. The facility should have documentation from the third 
party reprocessor confirming this is the case.
 Yes     No
D.  Reprocessing area:
i. Adequate space is allotted for reprocessing activities.
ii. A workflow pattern is followed such that devices clearly 
flow from high contamination areas to clean/sterile areas 
(i.e., there is clear separation between soiled and clean 
workspaces).
 Yes     No 
 Yes     No
E   Adequate time for reprocessing is allowed to ensure adherence 
to all steps recommended by the device manufacturer, 
including drying and proper storage.
Note: Facilities should have an adequate supply of instruments 
for the volume of procedures performed and should schedule 
procedures to allow sufficient time for all reprocessing steps.
 Yes     No
F.   HCP engaged in device reprocessing wear appropriate PPE to 
prevent exposure to infectious agents or chemicals (PPE can 
include gloves, gowns, masks, and eye protection). 
Note: The exact type of correct PPE depends on infectious or 
chemical agent and anticipated type of exposure.
 Yes     No
G.   Medical devices are stored in a manner to protect from 
damage and contamination.
 Yes     No
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XII. Sterilization of Reusable Devices 
(Note: If all device sterilization is performed off-site, skip to items M-O below.)
Elements to be assessed Assessment
Notes/Areas for 
Improvement
A.   Devices are thoroughly cleaned according to manufacturer 
instructions and visually inspected for residual soil prior to 
sterilization.
Note: Cleaning may be manual (i.e., using friction) and/or 
mechanical (e.g., with ultrasonic cleaners, washer-disinfector, 
washer-sterilizers).  
Ensure appropriately sized cleaning brushes are selected for 
cleaning device channels and lumens.  
 Yes     No  
 Not applicable    
B.   Cleaning is performed as soon as practical after use (e.g., at 
the point of use) to prevent soiled materials from becoming 
dried onto devices.
 Yes     No  
 Not applicable    
C.   Enzymatic cleaner or detergent is used for cleaning and 
discarded according to manufacturer’s instructions (typically 
after each use).
 Yes     No
 Not applicable    
D.   Cleaning brushes are disposable or, if reusable, cleaned 
and high-level disinfected or sterilized (per manufacturer’s 
instructions) after use.
 Yes     No
 Not applicable    
E.   After cleaning, instruments are appropriately wrapped/
packaged for sterilization (e.g., package system selected is 
compatible with the sterilization process being performed, 
items are placed correctly into the basket, shelf or cart of the 
sterilizer so as not to impede the penetration of the sterilant, 
hinged instruments are open, instruments are disassembled 
if indicated by the manufacturer).
 Yes     No
 Not applicable    
F.   A chemical indicator (process indicator) is placed correctly in 
the instrument packs in every load.
 Yes     No
 Not applicable    
G.   A biological indicator, intended specifically for the type and 
cycle parameters of the sterilizer, is used at least weekly for 
each sterilizer and with every load containing implantable 
items.
 Yes     No
 Not applicable    
H.   For dynamic air removal-type sterilizers (e.g., prevacuum 
steam sterilizer), an air removal test (Bowie-Dick test) is 
performed in an empty dynamic-air removal sterilizer each 
day the sterilizer is used to verify efficacy of air removal.
 Yes     No
 Not applicable    
I.   Sterile packs are labeled with a load number that indicates 
the sterilizer used, the cycle or load number, the date of 
sterilization, and, if applicable, the expiration date.
 Yes     No
 Not applicable    
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Elements to be assessed Assessment
Notes/Areas for 
Improvement
J.    Sterilization logs are current and include results from  
each load.
 Yes     No
 Not applicable    
K.   Immediate-use steam sterilization, if performed, is only 
done in circumstances in which routine sterilization 
procedures cannot be performed.
 Yes     No
 Not applicable    
L.   Instruments that undergo immediate-use steam sterilization 
are used immediately and not stored.
 Yes     No
 Not applicable    
M.   After sterilization, medical devices are stored so that sterility 
is not compromised.    
 Yes     No
 Not applicable    
N.   Sterile packages are inspected for integrity and 
compromised packages are reprocessed prior to use.
 Yes     No
 Not applicable    
O.   The facility has a process to perform initial cleaning of 
devices (to prevent soiled materials from becoming dried 
onto devices) prior to transport to the off-site reprocessing 
facility.
   Yes     No
   Not applicable 
XIII. High-Level Disinfection of Reusable Devices   
(Note: If all high-level disinfection is performed off-site, skip to items L-N below.)
Elements to be assessed Assessment
Notes/Areas for 
Improvement
A.   Flexible endoscopes are inspected for damage and leak tested 
as part of each reprocessing cycle.  Any device that fails the 
leak test is removed from clinical use and repaired.
 Yes     No
 Not applicable  
B.   Devices are thoroughly cleaned according to manufacturer 
instructions and visually inspected for residual soil prior to 
high-level disinfection. 
Note: Cleaning may be manual (i.e., using friction) and/or        
mechanical (e.g,. with ultrasonic cleaners, washer-disinfector, 
washer-sterilizers).
Ensure appropriately sized cleaning brushes are selected for 
cleaning device channels and lumens.  
 Yes     No
 Not applicable  
C.   Cleaning is performed as soon as practical after use (e.g., at 
the point of use) to prevent soiled materials from becoming 
dried onto instruments.
 Yes     No  
 Not applicable  
D.   Enzymatic cleaner or detergent is used and discarded 
according to manufacturer instructions (typically after each 
use).
 Yes     No
 Not applicable  
XII. Sterilization of Reusable Devices (continued)
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Elements to be assessed Assessment
Notes/Areas for 
Improvement
E.   Cleaning brushes are disposable or, if reusable, cleaned 
and high-level disinfected or sterilized (per manufacturer 
instructions) after use.
 Yes     No
 Not applicable  
F.   For chemicals used in high-level disinfection, manufacturer 
instructions are followed for: 
i. Preparation 
ii. Testing for appropriate concentration, and
iii. Replacement (i.e., upon expiration or loss of efficacy)
 Yes     No
 Yes     No
 Yes     No
 Not applicable  
G.   If automated reprocessing equipment is used, proper 
connectors are used to assure that channels and lumens are 
appropriately disinfected.
 Yes     No
 Not applicable  
H.   Devices are disinfected for the appropriate length of time as 
specified by manufacturer instructions.
 Yes     No
 Not applicable  
I.   Devices are disinfected at the appropriate temperature as 
specified by manufacturer instructions.
 Yes     No
 Not applicable  
J.   After high-level disinfection, devices are rinsed with sterile 
water, filtered water, or tap water followed by a rinse with 
70% - 90% ethyl or isopropyl alcohol.
Note: There is no recommendation to use sterile or filtered water 
rather than tap water for rinsing semi-critical equipment that 
contact the mucous membranes of the rectum or vagina
 Yes     No
 Not applicable  
K.  Devices are dried thoroughly prior to reuse. 
Note: For lumened instruments (e.g., endoscopes) this includes 
flushing all channels with alcohol and forcing air through 
channels.
 Yes     No
 Not applicable  
L.   After high-level disinfection, devices are stored in a manner 
to protect from damage or contamination.
Note: Endoscopes should be hung in a vertical position.
 Yes     No
 Not applicable  
M.   Facility maintains a log for each endoscopy procedure 
which includes: patient’s name and medical record number 
(if available), procedure, date, endoscopist, system used to 
reprocess the endoscope (if more than one system could be 
used in the reprocessing area), and serial number or other 
identifier of the endoscope used.
 Yes     No
 Not applicable  
N.   The facility has a process to perform initial cleaning of 
devices (to prevent soiled materials from becoming dried 
onto devices) prior to transport to the off-site reprocessing 
facility.
 Yes     No
 Not applicable  
XIII. High-Level Disinfection of Reusable Devices (continued)
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Section 4: Infection Control Guidelines and Other Resources
• General Infection Prevention 
 ❑ CDC/HICPAC Guidelines and recommendations: 
http://www.cdc.gov/HAI/prevent/prevent_pubs.html
• Healthcare Personnel Safety
 ❑ Guideline for Infection Control in Healthcare Personnel:  http://www.cdc.gov/hicpac/pdf/
InfectControl98.pdf
 ❑ Immunization of HealthCare Personnel:  http://www.cdc.gov/vaccines/spec-grps/hcw.htm
 ❑ Occupational Safety & Health Administration (OSHA) Bloodborne Pathogens and Needlestick 
Prevention Standard:  http://www.osha.gov/SLTC/bloodbornepathogens/index.html
 ❑ OSHA Respiratory Protection Standard:  https://www.osha.gov/pls/oshaweb/owadisp.show_
document?p_id=12716&p_table=STANDARDS
 ❑ OSHA Respirator Fit Testing: https://www.osha.gov/video/respiratory_protection/fittesting_
transcript.html
• Hand Hygiene
 ❑ Guideline for Hand Hygiene in Healthcare Settings:   
http://www.cdc.gov/mmwr/PDF/rr/rr5116.pdf
 ❑ Hand Hygiene in Healthcare Settings:  http://www.cdc.gov/handhygiene/
 ❑ Examples of tools that can be used to conduct a formal audit of hand hygiene practices:  
 – http://www.jointcommission.org/assets/1/18/hh_monograph.pdf
 – http://compepi.cs.uiowa.edu/index.php/Research/IScrub
• Personal Protective Equipment
 ❑ 2007 Guidelines for Isolation Precautions:  Preventing Transmission of Infectious Agents in 
Healthcare Settings:  http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf
 ❑ Guidance for the Selection and Use of Personal Protective Equipment in Healthcare Settings:  
http://www.cdc.gov/HAI/prevent/ppe.html
• Injection Safety
 ❑ 2007 Guidelines for Isolation Precautions:  Preventing Transmission of Infectious Agents in 
Healthcare Settings:  http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf
 ❑ CDC Injection Safety Web Materials: http://www.cdc.gov/injectionsafety/
 ❑ CDC training video and related Safe Injection Practices Campaign materials:   
http://www.oneandonlycampaign.org/
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• Respiratory Hygiene/Cough Etiquette
 ❑ 2007 Guidelines for Isolation Precautions:  Preventing Transmission of Infectious Agents in 
Healthcare Settings:  http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf
 ❑ Recommendations for preventing the spread of influenza:   
http://www.cdc.gov/flu/professionals/infectioncontrol/
• Environmental Cleaning
 ❑ Guidelines for Environmental Infection Control in Healthcare Facilities:   
http://www.cdc.gov/hicpac/pdf/guidelines/eic_in_HCF_03.pdf
 ❑ Options for Evaluating Environmental Infection Control:  
http://www.cdc.gov/HAI/toolkits/Evaluating-Environmental-Cleaning.html
• Equipment Reprocessing
 ❑ Guideline for Disinfection and Sterilization in Healthcare Facilities:  
http://www.cdc.gov/hicpac/pdf/guidelines/Disinfection_Nov_2008.pdf
 ❑ FDA regulations on reprocessing of single-use devices: http://www.fda.gov/MedicalDevices/
DeviceRegulationandGuidance/GuidanceDocuments/ucm071434
• Point-of-Care Testing
 ❑ Infection Prevention during Blood Glucose Monitoring and Insulin Administration:   
http://www.cdc.gov/injectionsafety/blood-glucose-monitoring.html
 ❑ Frequently Asked Questions (FAQs) regarding Assisted Blood Glucose Monitoring and Insulin 
Administration:  http://www.cdc.gov/injectionsafety/providers/blood-glucose-monitoring_faqs.html
• Resources to assist with evaluation and response to breaches in infection control
 ❑ Patel PR, Srinivasan A, Perz JF. Developing a broader approach to management of infection control 
breaches in health care settings. Am J Infect Control. 2008 Dec;36(10);685-90
 ❑ Steps for Evaluating an Infection Control Breach: http://www.cdc.gov/hai/outbreaks/steps_for_
eval_IC_breach.html
 ❑ Patient Notification Toolkit:  http://www.cdc.gov/injectionsafety/pntoolkit/index.html
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